Impact of emerging hepatitis C virus treatments on future needs for liver transplantation in France: a modelling approach.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sylvie,Deuffic-Burban

第一单位： Inserm U995, University of Lille Nord de France, Lille, France; Inserm ATIP-AVENIR, Denis Diderot University, Paris, France.

作者： Sylvie,Deuffic-Burban ^[1] ; Philippe,Mathurin ^[2] ; Isabelle,Rosa ^[3] ; Anne-Marie,Bouvier ^[4] ; Amélie,Cannesson ^[5] ; Abbas,Mourad ^[1] ; Valérie,Canva ^[5] ; Alexandre,Louvet ^[2] ; Pierre,Deltenre ^[6] ; Emmanuel,Boleslawski ^[7] ; Stéphanie,Truant ^[7] ; François-René,Pruvot ^[7] ; Sébastien,Dharancy ^[8]

作者单位： Inserm U995, University of Lille Nord de France, Lille, France; Inserm ATIP-AVENIR, Denis Diderot University, Paris, France. ^[1] Inserm U995, University of Lille Nord de France, Lille, France; Hepatology Unit, Claude Huriez Hospital, CHRU Lille, Lille, France. ^[2] Intercommunal Hospital, Créteil, France. ^[3] Inserm U866/Digestive Cancer Registry, Faculty of Medicine, Dijon, France; University Hospital, Burgundy University, Dijon, France. ^[4] Hepatology Unit, Claude Huriez Hospital, CHRU Lille, Lille, France. ^[5] Hepatology Unit, Claude Huriez Hospital, CHRU Lille, Lille, France; Hepato-Gastroenterology Unit, Jolimont Hospital, Haine-Saint-Paul, Belgium. ^[6] Digestive Surgery and Liver Transplantation Unit, Claude Huriez Hospital, CHRU Lille, Lille, France. ^[7] Inserm U995, University of Lille Nord de France, Lille, France; Hepatology Unit, Claude Huriez Hospital, CHRU Lille, Lille, France. Electronic address: sebastien.dharancy@chru-lille.fr. ^[8]

关键词 Direct-acting antiviral agents HCV epidemic Liver graft allocation Markov model Multi-organ procurement